CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoSORIA, Francesco
Dettaglio
SORIA, Francesco
SCIENZE CHIRURGICHE
Pubblicazioni
Risultati 1 - 20 di 111 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | A first pharmacokinetic study of mitomycin C intravesical thermo-chemotherapy for the treatment of superficial transitional cell carcinoma, "Beyond the Abstract," by Paola Milla, et al. | 2014 | Paola Milla; Chiara Fiorito; Francesco Soria; Silvia Arpicco; Luigi Cattel; Paolo Gontero |
| 2 | ABO blood group and rhesus factor are not associated with outcomes after radical cystectomy for non-metastatic urothelial carcinoma of the bladder | 2017 | D'andrea D.; Moschini M.; Soria F.; Gust K.M.; Briganti A.; Karakiewicz P.I.; Roupret M.; Shariat S.F. |
| 3 | Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool | 2018 | D'Andrea D.; Abufaraj M.; Susani M.; Ristl R.; Foerster B.; Kimura S.; Mari A.; Soria F.; Briganti A.; Karakiewicz P.I.; Gust K.M.; Roupret M.; Shariat S.F. |
| 4 | Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis. | 2011 | M. Oderda; E. Cattaneo; F. Soria; A. Barreca; L. Chiusa; B. Morelli; A. Zitella; P. Gontero |
| 5 | Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract | 2017 | Wirth G.J.; Haitel A.; Moschini M.; Soria F.; Klatte T.; Hassler M.R.; Bensalah K.; Briganti A.; Karam J.A.; Lotan Y.; Margulis V.; Raman J.D.; Remzi M.; Rioux-Leclercq N.; Robinson B.D.; Roupret M.; Wood C.G.; Shariat S.F. |
| 6 | Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer | 2021 | D'Andrea D.; Soria F.; Grotenhuis A.J.; Cha E.K.; Malats N.; Di Stasi S.; Joniau S.; Cai T.; van Rhijn B.W.G.; Irani J.; Karnes J.; Varkarakis J.; Baniel J.; Palou J.; Babjuk M.; Spahn M.; Ardelt P.; Colombo R.; Serretta V.; Dalbagni G.; Gontero P.; Bartoletti R.; Larre S.; Malmstrom P.-U.; Sylvester R.; Shariat S.F. |
| 7 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization | 2020 | D'Andrea D.; Abufaraj M.; Soria F.; Gust K.; Haitel A.; Krakiewicz P.I.; Shariat S.F. |
| 8 | Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: State of affairs and new frontiers | 2018 | Soria F.; Shariat S.F. |
| 9 | Bladder sparing landscape for bacillus Calmette-Guérin unresponsive bladder cancer | 2020 | Soria, Francesco; Giordano, Andrea; Shariat, Shahrokh F; Gontero, Paolo |
| 10 | The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort | 2020 | Muilwijk T.; Akand M.; Soria F.; Giordano A.; Milenkovic U.; Moris L.; Gevaert T.; Van Poppel H.; Albersen M.; Gontero P.; Joniau S. |
| 11 | Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer | 2017 | Soria F.; Lucca I.; Moschini M.; Mathieu R.; Roupret M.; Karakiewicz P.I.; Briganti A.; Rink M.; Gust K.M.; Hassler M.R.; Foerster B.; Abufarraj M.; Haitel A.; Klatte T.; Shariat S.F. |
| 12 | Characteristics and clinical significance of histological variants of bladder cancer | 2017 | Moschini M.; D'Andrea D.; Korn S.; Irmak Y.; Soria F.; Comperat E.; Shariat S.F. |
| 13 | Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients | 2017 | Soria, Francesco; Moschini, Marco; Wirth, Gregory J.; Gust, Kilian M.; Klatte, Tobias; Briganti, Alberto; Gontero, Paolo; Abufaraj, Mohammad; Özsoy, Mehmet; Karakiewicz, Pierre I.; Shariat, Shahrokh F. |
| 14 | Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy | 2018 | D'Andrea D.; Soria F.; Abufaraj M.; Gust K.; Foerster B.; Vartolomei M.D.; Kimura S.; Mari A.; Briganti A.; Remzi M.; Seitz C.K.; Mathieu R.; Karakiewicz P.I.; Shariat S.F. |
| 15 | Combination of urinary fibrinogen β-chain and tyrosine-phosphorylated proteins for the detection of bladder cancer | 2021 | Giribaldi G.; Filippini C.; Viberti C.; Khadjavi A.; Finesso N.; Ulliers D.; Turini S.; Bressan B.E.; Pecoraro F.; Prato M.; Allione A.; Bellis M.D.; Montefusco G.; Bonomessi G.; Allasia M.; Matullo G.; Soria F.; Gontero P. |
| 16 | Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study | 2020 | Soria, Francesco; Moschini, Marco; D'andrea, David; Abufaraj, Mohammad; Foerster, Beat; Mathiéu, Romain; Gust, Killian M.; Gontero, Paolo; Simone, Giuseppe; Meraney, Anoop; Krishna, Suprita; Konety, Badrinath; Rouprêt, Morgan; Perry, Matthew; Rowe, Edward; Ploussard, Guillaume; Boorjian, Stephen A.; Wiklund, Peter; Sooriakumaran, Prasanna; Shariat, Shahrokh F. |
| 17 | Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non–muscle-invasive Bladder Cancer | 2020 | D'Andrea D.; Soria F.; Abufaraj M.; Pones M.; Gontero P.; Machado A.T.; Waksman R.; Enikeev D.V.; Glybochko P.V.; Adonias S.P.; Nahas W.C.; Shariat S.F.; Chade D.C. |
| 18 | Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer | 2020 | D'Andrea D.; Soria F.; Zehetmayer S.; Stangl-Kremser J.; Grubmuller B.; Abufaraj M.; Gust K.; Kimura S.; Babjuk M.; Goldner G.M.; Shariat S.F. |
| 19 | Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysis | 2021 | Moschini M.; Zamboni S.; Afferi L.; Pradere B.; Abufaraj M.; Soria F.; D'Andrea D.; Roupret M.; De la Taille A.; Simeone C.; Mattei A.; Mathieu R.; Bensalah K.; Wirth M.P.; Montorsi F.; Briganti A.; Gallina A.; Simone G.; Gallucci M.; Di Bona C.; Marra G.; Mari A.; Di Trapani E.; Alvarez Maestro M.; Krajewski W.; Shariat S.F.; Xylinas E.; Baumeister P. |
| 20 | COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center | 2022 | Oderda M.; Soria F.; Rosi F.; Calleris G.; Mazzoli S.; Giordano A.; Pizzuto G.; Marquis A.; De Bellis M.; Vitiello F.; Vercelli E.; Peretti F.; Montefusco G.; Gontero P. |
Copyright © 2022